BioNTech COVID vaccine trial for damages commences in Germany.
TL;DR Summary
BioNTech is facing a lawsuit from a woman in Germany who claims that its COVID vaccine caused her to suffer damaging side effects. The trial is the first to deal with such allegations regarding a COVID vaccine in Germany. BioNTech says more than 64 million people in Germany and some 1.5 billion across the world received its Comirnaty vaccine, which it developed along with US pharmaceutical giant Pfizer. The European Medicines Agency (EMA) has approved it as safe.
Reading Insights
Total Reads
0
Unique Readers
10
Time Saved
2 min
vs 3 min read
Condensed
84%
483 → 78 words
Want the full story? Read the original article
Read on DW (English)